Author:
Mohajeri Ehsan,Ansari Mehdi,Pardakhty Abbas
Publisher
Maad Rayan Publishing Company
Subject
General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science
Reference30 articles.
1. Is imatinib still an acceptable first-line treatment for cml in chronic phase?;Goldman JM;Oncology (Williston Park),2012
2. Adverse Events after Imatinib Mesylate Therapy
3. Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation
4. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
5. A comparative in vitro drug release prospective with two different polymers for the development of floating single unit dosage form of imatinib mesylate for chronic myelogenous leukemia;Vinod KR;Ars Pharmaceutica,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献